| Product Name | MF | CAS | Details |
|---|
| Neuraminidase-IN-10 | C26H34N2O5S | 2685786-29-0 | Details |
| CDK7-IN-18 | C22H24F3N7OS | 2765676-81-9 | Details |
| Antileishmanial agent-11 | C27H24ClN3O4 | 2253635-71-9 | Details |
| ASP-4058 hydrochloride | C19H13ClF6N4O2 | 952510-14-4 | Details |
| Keap1-Nrf2-IN-5 | C23H30N4O6S | 2696272-70-3 | Details |
| ABL-L | C29H46O6 | 1613152-39-8 | Details |
| CBP/p300-IN-19 | C30H27N3O3 | 2592638-13-4 | Details |
| PRMT5-IN-16 | C25H34N8O2 | 2755304-16-4 | Details |
| ALK-IN-22 | C24H24ClN7O2 | 2468219-09-0 | Details |
| GSK2850163 hydrochloride | C24H30Cl3N3O | 2319838-09-8 | Details |
| Axl-IN-10 | C27H25N7O2 | 2487649-61-4 | Details |
| Antitubercular agent-32 | C22H28N4O5S2 | 2498762-42-6 | Details |
| AP5 sodium | C28H29FNNaO4 | 1623143-67-8 | Details |
| NTU281 | 815619-12-6 | Details |
| APJ receptor agonist 5 | C26H29N3O6 | 2135514-20-2 | Details |
| Antitumor agent-62 | C21H19N3O9S | 2460735-29-7 | Details |
| IHCH-3064 | C25H21N9O2 | 2420562-65-6 | Details |
| EGFR-IN-36 | C26H25ClN6O2 | 2711105-54-1 | Details |
| ERK5-IN-3 | C24H23Cl2FN4O2 | 1888305-85-8 | Details |
| hCAXII-IN-4 | C22H27N5O6S | 2414601-79-7 | Details |
| AT2R antagonist 1 | C23H30N4O4S2 | 2709031-17-2 | Details |
| FAK inhibitor 6 | 2410056-27-6 | Details |
| GRK5-IN-4 | C26H25N7O3 | 2410794-89-5 | Details |
| Glutaminase-IN-4 | C23H22N6O2S2 | 1439390-05-2 | Details |
| SJ000025081 | C28H30FNO5 | 421571-66-6 | Details |
| BGC-20-1531 free base | C26H24N2O6S | 736183-35-0 | Details |
| PDGFRα/FLT3-ITD-IN-3 | C26H39N9 | 2761259-22-5 | Details |
| EGFR/HER2/CDK9-IN-3 | C24H21N3O4S2 | 422276-47-9 | Details |
| IRAK4-IN-15 | C25H29FN10 | 2667681-85-6 | Details |
| iNOs-IN-3 | C27H24N2O5S | 2241674-94-0 | Details |
| Antibacterial agent 101 | C28H29BrN2O | 2452306-15-7 | Details |
| Antibacterial agent 104 | C28H39NO4S | 2095612-29-4 | Details |
| VS 8 | C26H20F3N3O3 | 2471865-38-8 | Details |
| Estrogen receptor antagonist 2 | C26H31F4N5 | 2735803-90-2 | Details |
| Axl-IN-7 | C29H26N6O2 | 1770821-83-4 | Details |
| γ-Secretase modulator 11 | C28H22F2N4O2 | 2434630-29-0 | Details |
| ZIKV-IN-1 | C21H18BrF2N3O3 | 2762166-06-1 | Details |
| FXa-IN-1 | C24H18F5N5O | 441328-10-5 | Details |
| DHODH-IN-20 | C24H25F4N3O3 | 2639835-02-0 | Details |
| (R)-MALT1-IN-7 | C19H17F3N8O2S | 2178993-10-5 | Details |
| AKT-IN-10 | C26H34ClN5O2 | 2709045-56-5 | Details |
| KU-177 | C27H23NO8 | 1160952-43-1 | Details |
| IDH2R140Q-IN-1 | C22H20F6N6 | 2469044-23-1 | Details |
| ChemR23-IN-4 | C27H26N6O3 | 2465085-23-6 | Details |
| EGFR-IN-38 | C25H24ClN7O2 | 2711105-50-7 | Details |
| JAK2/TYK2-IN-1 | C19H13F4N7O2S | 2613434-12-9 | Details |
| Apoptosis inducer 6 | C27H26N4O3S | 2529913-90-2 | Details |
| α-Glucosidase-IN-6 | C24H17ClF3NO3S | 2497685-29-5 | Details |
| MIF-IN-4 hydrochloride | C26H29ClN6O2 | 2489514-05-6 | Details |
| β-catenin-IN-3 | C19H20Br2N2OS | 1005288-15-2 | Details |
| RET-IN-6 | C30H29N7 | 2715208-83-4 | Details |
| FLT3-IN-17 | C23H24N6O2S2 | 2758999-62-9 | Details |
| PD-1/PD-L1-IN-25 | C26H24ClN3O5 | 2768759-52-8 | Details |
| BTK-IN-11 | C26H22ClN5O3 | 2765852-46-6 | Details |
| AMPK activator 8 | C25H21ClN2O6 | 1852451-96-7 | Details |
| BTK-IN-9 | C25H19N7O4 | 2361192-21-2 | Details |
| HBV-IN-22 | C26H29N3O2S2 | 2338573-94-5 | Details |
| AChE-IN-6 | C29H41N5O2 | 2758788-95-1 | Details |
| RORγt modulator 4 | C26H27N3O4S | 2188177-73-1 | Details |
| MALT1-IN-7 | C19H17F3N8O2S | 2178993-11-6 | Details |
| PP2A Cancerous-IN-1 | C30H24N4O3 | 1403933-79-8 | Details |
| FLT3/CDK4-IN-1 | C25H28F2N8 | 2762296-44-4 | Details |
| AVG-233 | C26H22ClN5O3 | 2151937-80-1 | Details |
| AChE/HDAC-IN-1 | C26H27ClN4O3 | 2414053-06-6 | Details |
| LX-039 | C27H20Cl2FNO2 | 2135341-09-0 | Details |
| Antifungal agent 31 | C25H22F2N6O3 | 2077083-94-2 | Details |
| MET kinase-IN-3 | C25H16ClF2N5O2 | 1446324-02-2 | Details |
| PI3Kδ/γ-IN-2 | C25H21ClN8O | 2412195-89-0 | Details |
| MMP-9-IN-3 | C29H25N3O4 | 2581824-48-6 | Details |
| CDK7-IN-15 | C21H24F4N6OS | 2765676-02-4 | Details |
| DENV-IN-5 | C23H25ClF2N4OS | 2375781-06-7 | Details |
| hCAIX-IN-10 | C28H21N3O3S | 2497504-72-8 | Details |
| COX-2-IN-22 | C29H24O7 | 2447589-08-2 | Details |
| FLT3/ITD-IN-2 | C23H26F3N7O2 | 2489446-59-3 | Details |
| Antitrypanosomal agent 7 | C23H29N5O2 | 2492436-38-9 | Details |
| P2X3 antagonist 36 | C20H18ClF3N6O3 | 2310263-59-1 | Details |
| Aβ-IN-1 | 2766509-32-2 | Details |
| Factor XI-IN-1 | C30H38N4O2 | 2720619-72-5 | Details |
| Axl-IN-6 | C32H36N4O | 2642224-22-2 | Details |
| B10-S | C22H14ClF3N4O2S | 2210238-26-7 | Details |
| SARS-CoV-2-IN-32 | C27H23N5O4 | 96068-42-7 | Details |
| PDE5-IN-5 | C23H20BrN3O4 | 2414921-33-6 | Details |
| Antiviral agent 19 | C29H35NO5 | 1807887-16-6 | Details |
| PI3K-IN-33 | C23H21BrN6O2 | 2458163-92-1 | Details |
| VEGFR-2-IN-26 | C24H19F3N6O2 | 2439096-06-5 | Details |
| HSP90-IN-13 | C26H21N5O3S | 2446055-29-2 | Details |
| GRP78-IN-2 | C29H29NO6 | 1882875-63-9 | Details |
| Neuraminidase-IN-3 | C27H32N2O4S | 2699874-41-2 | Details |
| Androgen receptor antagonist 5 | C21H15F4N5O3S | 2586195-28-8 | Details |
| EGFR-IN-33 | C26H25ClN6O2 | 2711105-59-6 | Details |
| RET-IN-8 | C27H30N6O3 | 2642164-75-6 | Details |
| HDAC1/2 and CDK2-IN-1 | C26H22ClN7O | 2418559-01-8 | Details |
| LSD1-IN-20 | C27H38N6O2 | 1239589-91-3 | Details |
| IRAK4-IN-14 | C25H28FN9O | 2667681-71-0 | Details |
| Cas9-IN-2 | C21H27N5O4S2 | 1030133-34-6 | Details |
| RET-IN-9 | C26H27N9O | 2649418-11-9 | Details |
| ALPK1-IN-1 | C25H32N6O2S | 2765457-72-3 | Details |
| CFI-400437 | C29H28N6O2 | 1169211-37-3 | Details |
| T-2513 hydrochloride | C25H28ClN3O5 | 187793-52-8 | Details |
| HPK1-IN-29 | C26H18F3N5O2 | 2699604-50-5 | Details |
| Product Total： Product Page： | ||||
| 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 | ||||